NL-OMON50198
Completed
Phase 4
Pharmacokinetics of a new paediatric formulation of valacyclovir used for prophylaxis and treatment of VZV and HSV infections in children (VALID II). - VALID-2
Afdeling Apotheek0 sites7 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Afdeling Apotheek
- Enrollment
- 7
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Trial ended prematurely
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Subject is in the age of 1\-12 years.
- •2\. Subject receives (val)acyclovir prophylaxis and is planned to receive
- •valacyclovir oral solution.
- •3\. Subject is managed with a central venous catheter (CVC/Port\-a\-Cath).
- •4\. Subject\*s parents have signed the Informed Consent Form prior to screening
- •evaluations.
Exclusion Criteria
- •1\. Severe anemia (Hb \< 5\.0 mmol/L).
- •2\. Full dose has not been taken.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Pharmacokinetic testing of a new paediatric formulation of valacyclovir.Herpes virus infections, especially Herpes Simplex and Varicella Zoster.MedDRA version: 20.0Level: PTClassification code 10019973Term: Herpes virus infectionSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2017-001451-30-NLRadboud university medical center16
Completed
Not Applicable
Acceptability study of a new paediatric formulation of Orphacol® (cholic acid) in paediatric patients treated for inborn errors in primary bile acid synthesis due to 3ß-Hydroxy-?5-C27- steroid oxidoreductase deficiency or ?4-3-Oxosteroid-5ß-reductase deficiency.K76.8Other specified diseases of liverDRKS00013645aboratoires CTRS4
Recruiting
Not Applicable
Palatability testing of a new paediatric formulation of valacyclovir for the prophylaxis and treatment of VZV and HSV infections in children - VALID 0chickenpoxherpes10047438NL-OMON43617niversitair Medisch Centrum60
Active, not recruiting
Phase 1
Palatability testing of a new paediatric formulation of valacyclovirHerpes virus infections, especially Herpes Simplex, Varicella Zoster and CytomegalovirusMedDRA version: 14.1Level: PTClassification code 10019973Term: Herpes virus infectionSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2012-000577-22-NLRadboud University Nijmegen Medical Centre64
Completed
Phase 1
A Study In Adult Healthy Volunteers To Asses Once Daily (QD) Dosing With The Selected Age-Appropriate Modified Release (MR) FormulationsHealthyNCT04338711Pfizer23